Driving reinvestment in R&D for antibiotics and advocating their responsible use


WHO releases ‘Worldwide country situatuation analysis: Response to antimicrobial resistance’

In April, 2015, the World Health Organization (WHO) released a new report titled Worldwide country situation analysis: response to antimicrobial resistance on what countries around the world are doing to address the antimicrobial resistance crisis.
Although (antimicrobial resistance is) widely recognized as an urgent problem by many international organizations and ministries of health, not all countries have a response plan to tackle antimicrobial resistance. Some regions face other, more pressing problems, and many low- to middle-income countries do not have the resources to implement response mechanisms. A “country situation analysis” was subsequently conducted in countries in each of the six WHO regions to assess current...
Read more

ReAct launches Toolbox for taking action on antibiotic resistance

On April 28, the ReAct network launched their ReAct Toolbox: a web-based resource offering hands-on advice and a comprehensive practical framework, to facilitate efforts toward managing the issue of antibiotic resistance. The aim of the Toolbox is to provide inspiration and guidance on what can be done to address antibiotic resistance, based on what has been done in the past, and what is being done now. It features input from the whole ReAct network, as well as that of other important stakeholders. The freshly gathered and ever-evolving contents will include an abundance of advice along with real-life, expert narratives, focusing on aspects such as understanding...
Read more

DRIVE-AB featured at ECCMID 2015 in Copenhagen

DRIVE-AB received significant attention at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2015 in Copenhagen, Denmark, this year. The congress ran from the 25th to 28th of April, and incorporated a series of lectures, symposium, educational workshops and meet-the-expert sessions which covered the entire field of infectious diseases and clinical microbiology. DRIVE-AB was discussed in a presentation by Inge Gyssens, Work Package 1A academic leader, titled What is responsible use? View of low-resistance countries on Sunday, April 26. The project was also featured on a Center for Anti-Infective Agents (CEFAIA) poster at the Pipeline Corner titled "Antibacterial drug research...
Read more

European Commission Releases Road Map to Combat Antimicrobial Resistance

European Commission releases an Action Plan Against the rising threats from Antimicrobial Resistance:Road MapThe plan introduces seven major goals to curb the threat of resistance, with recommendations for each:
  1. Promote appropriate use of antimicrobials
  2. Prevent microbial infections and their spread
  3. Develop new effective antimicrobials or alternatives for treatment
  4. Join forces with international partners to contain the risks of spreading AMR from international trade and travel and via the environment - DRIVE-AB is mentioned in this category
  5. Improve monitoring and surveillance
  6. Further research and innovation
  7. Strengthen communication, education and training
Read more

US White House releases 5 year strategy to combat antibacterial resistance

On Friday, 27th March the United States of America released an official 5 year strategy to combat antibacterial resistance. The move comes after the recognition of antibacterial resistance as a major global health threat, and the 2016 budget proposal released in January that proposes $1.2 billion (USD) funding for antibiotic resistance. The goals of the 5 year strategy are as follows; 1. Slow the emergence of resistant bacteria and prevent the spread of resistant infections 2. Strengthen national One-Health surveillance efforts to combat resistance 3. Advance development and use of rapid and innovative diagnostic tests for identification and characterization of resistant bacteria 4. Accelerate basic and applied research and development for new...
Read more